Nuclear Medicine and Biology
Volume 33, Issue 8 , Pages 977-984 , November 2006

Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells

Received 16 May 2006 ,Revised 4 August 2006 ,Accepted 7 August 2006.

References 

  1. Anastasiadis AG, Stisser BC, Ghafar MA, Burchardt M, Buttyan R. Tumor hypoxia and the progression of prostate cancer. Curr Urol Reports. 2002;3:222–228
  2. Schöder H, Steven M, Larson MD. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004;34:274–292
  3. Morris MJ, Akhurst T, Osman I, Nunez R, Macapinlac H, Siedlecki K, et al. Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer. Urology. 2002;59:913–918
  4. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39:990–995
  5. Oyama N, Akino H, Kanamaru H, Suzuki Y, Muramoto S, Yonekura Y, et al. 11C-acetate PET imaging of prostate cancer. J Nucl Med. 2002;43:181–186
  6. DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001;61:110–117
  7. Price DT, Coleman RE, Liao RP, Polascik TJ, Robertson CN, DeGrado TR. Comparison of [18F]fluorocholine and [18F]fluorodeoxyglucose in positron emission tomography (PET) imaging of androgen-dependent and androgen-independent prostate cancer. J Urol. 2002;168:273–280
  8. Hara T, Kosaka N, Kishi H. Development of 18F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med. 2002;43(2):187–199
  9. Kotzerke J, Volkmer BG, Glattig G, van den Hoff J, Gschwend JE, Messer P, et al. Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer. Nuklearmedizin. 2003;42:25–30
  10. Nakagami K, Uchida T, Ohwada S, et al. Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J Cancer Res. 1999;90:419–424
  11. Ramirez de Molina A, Gutierrez R, Ramos MA, Silva JM, Silva J, Bonilla F, et al. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy. Oncogene. 2002;21:4317–4322
  12. Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez J, Bonilla F, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun. 2002;296:580–583
  13. Löffler M, Schneider F. Lipogenesis in Ehrlich ascites tumor cells under anaerobic culture conditions. J Cancer Res Clin Oncol. 1979;95:115–122
  14. Pauwels EKJ, Sturm EJC, Bombardieri E, Cleton FJ, Stokkel MPM. Positron emission tomography with [18F]fluorodeoxyglucose: Part 1. Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol. 2000;126:549–559
  15. Clavo AC, Brown RS, Wahl RL. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med. 1995;36:1625–1632
  16. Burgman P, O'Donoghue JA, Humm JL, Ling CC. Hypoxia-induced increase in FDG uptake in MCF7 cells. J Nucl Med. 2001;42:170–175
  17. Chappell JB. The oxidation of citrate, isocitrate and cis-aconitate by isolated mitochondria. Biochem J. 1964;90:225–237
  18. Jones KH, Senft JA. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate–propidium iodide. J Histochem Cytochem. 1985;33:77–79
  19. Movsas B, Chapman JD, Greenberg RE, Hanlon AL, Horwitz EM, Pinover WH, et al. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO2 study. Cancer. 2000;89:2018–2024
  20. Parker C, Milosevoic M, Toi A, Sweet J, Panzarella T, Bristow R, et al. Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004;58:750–757
  21. Kurdziel KA, Fig WD, Carrasquillo JA, Huebsch S, Whatley M, Sellers D, et al. Using positron emission tomography 2-deoxy-2-[18F]fluoro-d-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer. Mol Imaging Biol. 2003;5:86–93
  22. Prabhakar NR. Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol. 2001;90:1986–1994
  23. Marcussen M. Induction of cell surface blebbing by increased cellular Pi concentration. Biochem J. 1996;318:955–958
  24. Anastasiadis AG, Ghafar MA, Salomon L, Vacherot F, Benedit P, Chen MW, et al. Human hormone-refractory prostate cancers can harbor mutations in the O2-dependent degradation domain of hypoxia-inducible factor 1α (HIF-1α). J Cancer Res Clin Oncol. 2002;128:358–362
  25. Ishidate K. Choline transport and choline kinase. In:  Vance DE editors. Phosphatidylcholine metabolism. Boca Raton (FL): CRC Press; 1989;p. 9–32
  26. Yoshimoto M, Waki A, Obata A, Furukawa T, Yonekura Y, Fujibayashi Y. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nucl Med Biol. 2004;31:859–865
  27. Spencer TL, Lehninger AL. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol. 1993;264:C761–C782
  28. Yoshimoto M, Waki A, Yonekura Y, Sadato N, Murata T, Omata N, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol. 2001;28:117–122
  29. Hillered L, Valtysson J, Enblad P, Persson L. Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain. J Neurol Neurosurg Psychiatry. 1998;64(4):486–491
  30. Wardle CA, Riemersma RA. Hypoxia-stimulated glycerol production from the isolated, perfused rat heart is mediated by non-adrenergic mechanisms. Basic Res Cardiol. 1994;89:29–38
  31. Joseph IB, Nelson JB, Denmeade SR, Isaacs JT. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue. Clin Cancer Res. 1997;3:2507–2511
  32. Levine AC, Liu XH, Greenberg PD, Eliashvili M, Schiff JD, Aaronson SA, et al. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology. 1998;139:4672–4678
  33. Swinnen JV, Van Veldhoven PP, Esquenet M, Heyns W, Verhoeven G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology. 1996;137:4468–4474
  34. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res. 1997;15:1086–1090
  35. Mabjeesh NJ, Willard MT, Frederickson CE, Zhong H, Simons JW. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3′-kinase/protein kinase B in prostate cancer cells. Clin Cancer Res. 2003;9:2416–2425
  36. Kishi H, Minowada S, Kosaka N, Hara T. 11C-choline PET helps determine the outcome of hormonal therapy of prostate cancer. J Nucl Med. 2002;43(Suppl.):117P
  37. Chawla RK, Wolf DC, Kutner MH, Bonkovsky HC. Choline may be an essential nutrient in malnourished patients with cirrhosis. Gastroenterology. 1989;97:1514–1520
  38. Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice L, et al. Lecithin increases plasma free choline and decreases hepatic steatosis. Gastroenterology. 1992;102:1363–1370
  39. Tollinger CD, Vreman HJ, Weiner MW. Measurement of acetate in human blood by gas chromatography: effects of sample preparation, feeding, and various diseases. Clin Chem. 1979;25:1787–1790

PII: S0969-8051(06)00156-9

doi: 10.1016/j.nucmedbio.2006.08.002

Nuclear Medicine and Biology
Volume 33, Issue 8 , Pages 977-984 , November 2006

Article Tools

* Image Usage & Resolution